Ignore the News, Part 2

Many participants, however, thought it unlikely that the data available in June would provide sufficient confirmation that the conditions for raising the target range for the federal funds rate had been satisfied, although they generally did not rule out this possibility. This big story from Business Insider, as shown above, is that a fed rate… Continue reading Ignore the News, Part 2

Evidence That America Is Not In Decline (long post)

Rumors of America’s decline have been exaggerated. Vox Day, in a recent post, writes: What we are witnessing is nothing less than the gradual demise of the biggest, wealthiest economy in world history. It is truly a privilege and an education to behold. It is rather like being able to witness the death of the… Continue reading Evidence That America Is Not In Decline (long post)

Good Tweets

If you cheer for catastrophe to happen so that you can implement your desired radical social and political change, you're doing it wrong. — Noah Smith (@Noahpinion) May 16, 2015 That seems to describe how the left wanted the 2008 financial problem to get worse in order to get Obama elected, who would user in… Continue reading Good Tweets

Salvation Through IQ

Americans but especially millennials are eschewing the traditional religions for a new ‘religion’ that celebrates not deities, sacred scriptures, or saints – but intellect, wealth, authenticity, and individualism. While idolatry is not a new concept, what makes this trend different is that unlike the young adults of of earlier generations who fawned over the ‘mainstream’… Continue reading Salvation Through IQ

Being A Liberal…

…means pretending to be ‘pro-science’, yet being offended by the science that shows IQ is important and congenital. …means being offended by the economic reality that maybe some people, by virtue of their intelligence, contribute more to the economy than others and are hence more ‘valuable’. …means believing that wasteful government spending can reverse problems… Continue reading Being A Liberal…

The Healthcare Scam

Vertex’s Cystic-Fibrosis Drug Faces Big Test Vertex, based in Boston, Mass., already has a hit cystic-fibrosis drug in Kalydeco, which has a wholesale annual per-patient price of $311,000 in the U.S., and had $464 million in global sales last year. But Kalydeco treats a relatively rare type of cystic fibrosis, with a market of only… Continue reading The Healthcare Scam